Clinical trials: PFO - Patent Foramen Ovale

Patent Foramen Ovale

Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO)

• Unknown status
• Age: 18 to 80 years
• Phase 4
• Medical device

Background and hypothesis: The appropriate treatment strategy for secondary stroke prevention in patients with cryptogenic stroke and patent foramen ovale (PFO) remains challenging.

Trial name

NCT01550588

Testing

Device closure, Standard medical treatment

Where

4 sites in South Korea

Volunteers

210 people

Sponsor

Jae-Kwan Song